INS and Hypoglycemia: In the interim, we suggest that our pragmatic approach to detecting likely significant anti‐insulin antibodies is applicable in current practice and should be considered in any insulin‐treated participant with unexplained labile glycaemia, particularly where overnight hypoglycaemia and postprandial hyperglycaemia are prominent.